Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?
Should You Hold Edwards Lifesciences Stock in Your Portfolio?
Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings
Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care
$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?
Edwards Lifesciences: Strong Execution, But Little Room For Error At $90
Edwards Lifesciences: Cheap Against Itself, Expensive Against Everything Else
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
Leerink Partners Upgrades Edwards Lifesciences (EW)
Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium
Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat
JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105
Edwards lifts FY26 growth outlook following steady Q2 performance
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary
Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.